153 related articles for article (PubMed ID: 3422575)
1. Secondary leukemia after severe aplastic anemia.
Tichelli A; Gratwohl A; Würsch A; Nissen C; Speck B
Blut; 1988 Feb; 56(2):79-81. PubMed ID: 3422575
[TBL] [Abstract][Full Text] [Related]
2. [Immunosuppression, bone marrow infusion and low dose androgens, successful therapy of severe aplastic anemia].
Cornu P; Speck B; Gratwohl A; Nissen C; Sartorius J; Jeannet M
Schweiz Med Wochenschr; 1979 Sep; 109(37):1384-5. PubMed ID: 384511
[TBL] [Abstract][Full Text] [Related]
3. Late haematological complications in severe aplastic anaemia.
Tichelli A; Gratwohl A; Würsch A; Nissen C; Speck B
Br J Haematol; 1988 Jul; 69(3):413-8. PubMed ID: 3044440
[TBL] [Abstract][Full Text] [Related]
4. Morphology in patients with severe aplastic anemia treated with antilymphocyte globulin.
Tichelli A; Gratwohl A; Nissen C; Signer E; Stebler Gysi C; Speck B
Blood; 1992 Jul; 80(2):337-45. PubMed ID: 1627795
[TBL] [Abstract][Full Text] [Related]
5. [Acute monocytic leukemia following anti-lymphocyte immunoglobulin treatment in a patient with severe aplastic anemia].
Ohbayashi Y; Nagai M; Sasaki K; Murata M; Tasaka T; Kubota Y; Ikeda K; Takahara J; Irino S
Rinsho Ketsueki; 1993 May; 34(5):673-5. PubMed ID: 8315841
[TBL] [Abstract][Full Text] [Related]
6. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
7. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
[TBL] [Abstract][Full Text] [Related]
8. Transformation of severe aplastic anemia into acute myeloblastic leukemia with monosomy 7.
Hashino S; Imamura M; Tanaka J; Kobayashi S; Musashi M; Kasai M; Asaka M
Ann Hematol; 1996 May; 72(5):337-9. PubMed ID: 8645749
[TBL] [Abstract][Full Text] [Related]
9. Effect of antilymphocyte globulin (ALG) on bone marrow T/non-T cells from aplastic anaemia patients and normal controls.
Tong J; Bacigalupo A; Piaggio G; Figari O; Marmont A
Br J Haematol; 1989 Dec; 73(4):546-50. PubMed ID: 2692693
[TBL] [Abstract][Full Text] [Related]
10. [Complete remission achieved by low-dose Ara-C, aclarubicin and rhG-CSF (CAG) therapy in acute non-lymphocytic leukemia with monosomy 7 occurring after severe aplastic anemia].
Yamato H; Yamada K; Koike T; Yoshida M; Tsunogake S; Aoyagi M; Nakamura Y; Watanabe K; Saito K; Enokihara H
Rinsho Ketsueki; 1995 Feb; 36(2):128-33. PubMed ID: 7536277
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of severe aplastic anemia].
Gratwohl A; Osterwalder B; Nissen C; Leibundgut U; Signer E; Lüthy A; Jeannet M; Speck B
Schweiz Med Wochenschr; 1981 Oct; 111(41):1520-2. PubMed ID: 7031870
[TBL] [Abstract][Full Text] [Related]
12. [Bone marrow transplantation in severe aplastic anemia and acute leukemia].
Speck B; Sartorius J; Cornu P; Nissen C; Weber W; Gratwohl A
Onkologie; 1979 Apr; 2(2):79-82. PubMed ID: 42865
[TBL] [Abstract][Full Text] [Related]
13. Aplasia leukaemia syndrome.
Lancet; 1989 Jun; 1(8652):1425-7. PubMed ID: 2567433
[No Abstract] [Full Text] [Related]
14. [Effectiveness of antilymphocyte and antithymocyte globulins for patients with severe aplastic anemia and pure red cell aplasia--analysis of immunologic parameters of peripheral lymphocytes concerning ALG and ATG therapy].
Kawauchi K; Sugiyama H; Watanabe H; Urabe A; Takaku F
Rinsho Ketsueki; 1990 Jan; 31(1):10-5. PubMed ID: 2107342
[TBL] [Abstract][Full Text] [Related]
15. [Complete remission in a case of aplastic anemia after treatment with antilymphocyte globulin (author's transl)].
Silingardi V; Venezia L; Federico M; Torelli G; Salvo G
Haematologica; 1979 Feb; 64(1):66-76. PubMed ID: 109367
[No Abstract] [Full Text] [Related]
16. Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia.
Tichelli A; Passweg J; Nissen C; Bargetzi M; Hoffmann T; Wodnar-Filipowicz A; Signer E; Speck B; Gratwohl A
Br J Haematol; 1998 Feb; 100(2):393-400. PubMed ID: 9488634
[TBL] [Abstract][Full Text] [Related]
17. Late clonal complications in severe aplastic anemia.
Tichelli A; Gratwohl A; Nissen C; Speck B
Leuk Lymphoma; 1994 Jan; 12(3-4):167-75. PubMed ID: 8167549
[TBL] [Abstract][Full Text] [Related]
18. [Antilymphocyte globulin in the treatment of aplastic anemia].
Malesević M; Tukić L; Stamatović D; Trajković Z; Krstić C
Med Pregl; 1993; 46(7-8):291-5. PubMed ID: 7968829
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party.
Bacigalupo A; Hows J; Gluckman E; Nissen C; Marsh J; Van Lint MT; Congiu M; De Planque MM; Ernst P; McCann S
Br J Haematol; 1988 Oct; 70(2):177-82. PubMed ID: 3056497
[TBL] [Abstract][Full Text] [Related]
20. Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity.
Marsh JC; Hows JM; Bryett KA; Al-Hashimi S; Fairhead SM; Gordon-Smith EC
Blood; 1987 Oct; 70(4):1046-52. PubMed ID: 3651599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
